UROV - Urovant Sciences' (UROV) CEO Jim Robinson on Q2 2020 Results - Earnings Call Transcript

Urovant Sciences Ltd. (UROV) Q2 2020 Earnings Conference Call November 2, 2020 4:30 PM ET Company Participants Ryan Kubota – Investor Relations Jim Robinson – President and Chief Executive Officer Ajay Bansal – Chief Financial Officer Cornelia Haag-Molkenteller – Chief Medical Officer Conference Call Participants Ram Selvaraju – H.C. Wainwright Biren Amin – Jefferies Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Urovant Sciences Fiscal Year Second Quarter 2020 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference to your speaker today, Ryan Kubota, Investor Relations. Please go ahead, sir. Ryan Kubota Thank you, operator. Good afternoon, and thank you all for joining Urovant’s fiscal 2020 second quarter financial results conference call. With me today are key members of our leadership team; Jim Robinson, President and Chief Executive Officer;

For further details see:

Urovant Sciences' (UROV) CEO Jim Robinson on Q2 2020 Results - Earnings Call Transcript